369 related articles for article (PubMed ID: 8106159)
21. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
[TBL] [Abstract][Full Text] [Related]
22. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
[TBL] [Abstract][Full Text] [Related]
23. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic profile of carvedilol.
Hombach V; Kochs M; Höher M; Eggeling T; Haerer W; Wieshammer S; Schmidt A
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S101-3. PubMed ID: 1974496
[TBL] [Abstract][Full Text] [Related]
25. Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.
Mizuochi Y; Okajima K; Harada N; Molor-Erdene P; Uchiba M; Komura H; Tsuda T; Katsuya H
Transl Res; 2007 Apr; 149(4):223-30. PubMed ID: 17383596
[TBL] [Abstract][Full Text] [Related]
26. The pharmacology of carvedilol.
Ruffolo RR; Gellai M; Hieble JP; Willette RN; Nichols AJ
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S82-8. PubMed ID: 1974511
[TBL] [Abstract][Full Text] [Related]
27. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
Feuerstein G; Ruffolo RR
Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
[No Abstract] [Full Text] [Related]
28. Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
Acta Med Scand Suppl; 1985; 693():115-20. PubMed ID: 2859739
[TBL] [Abstract][Full Text] [Related]
29. Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
Kawada T; Ishibashi T; Nakazawa M; Satoh S; Imai S
J Cardiovasc Pharmacol; 1990 Jul; 16(1):147-53. PubMed ID: 1696657
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacology of multiple action compounds.
Prichard BN; Tomlinson B
Z Kardiol; 1989; 78 Suppl 3():1-6. PubMed ID: 2573211
[TBL] [Abstract][Full Text] [Related]
31. Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failure.
Ruffolo RR; Feuerstein GZ; Ohlstein EH
Am J Hypertens; 1998 Jan; 11(1 Pt 2):9S-14S. PubMed ID: 9503101
[TBL] [Abstract][Full Text] [Related]
32. Carvedilol in ischaemic heart disease.
Prichard BN
Cardiology; 1993; 82 Suppl 3():34-9. PubMed ID: 8106163
[TBL] [Abstract][Full Text] [Related]
33. Influence of salt intake on the antihypertensive effect of carvedilol.
Ruilope LM; Lahera V
J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Qvigstad E; Sjaastad I; Bøkenes J; Schiander I; Solberg L; Sejersted OM; Osnes JB; Skomedal T
Eur J Pharmacol; 2005 May; 516(1):51-9. PubMed ID: 15916756
[TBL] [Abstract][Full Text] [Related]
35. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
Eggertsen R; Andrén L; Sivertsson R; Hansson L
Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
[TBL] [Abstract][Full Text] [Related]
36. [Multiple action neuro-hormonal antagonist: carvedilol].
Taurand S
Soins; 1997 Oct; (619):61-2. PubMed ID: 9416217
[No Abstract] [Full Text] [Related]
37. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol.
Frishman WH
Indian Heart J; 1999; 51(3):325-32. PubMed ID: 10624077
[No Abstract] [Full Text] [Related]
39. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
Sponer G; Bartsch W; Strein K; Müller-Beckmann B; Böhm E
J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
